This invention relates in general to an apparatus for delivering fluids and more particularly to an apparatus for safely and effectively delivering fluid medication to infants and toddlers.
Infants and toddlers often resist the administering of medicine or refuse to ingest the medicine once administered. A syringe or eyedropper is typically used to administer medicine to infants and toddlers, which are often times sensed as a foreign object. As a result, the infant often will seek to push the object away from or out of its mouth. Even if the infant has adjusted to a syringe or eyedropper, the unfamiliar taste of many medicines will still cause the infant to spit out the medicine once it has been administered.
Syringes and eyedroppers are usually rigid, and in the case of a struggling infant, could possibly be dangerous to the infant's eyes, mouth, and throat. When actually administering the medication if it is injected directly to the back of the throat it often causes a gag reflex. This reflex causes the infant to spit up an unmeasurable amount of the medicine. The important question of proper dosage arises when the medicine has been spilled or spit out by the infant or toddler. It becomes very difficult to estimate or measure how much medicine has been ingested and how much medicine still needs to be given for a proper dosage when the infant refuses a portion of the medicine. There is not only the obvious risk of over dosage, but the risk of under dosage making the medicine ineffective. An under dosage could be as significant as an over dosage if the medicine is critically needed by the infant.
Thus, it would be desirable to provide an improved apparatus for safely and effectively delivering medication in to infants and toddlers.
This invention relates to an improved apparatus for safely and effectively delivering fluid medication to infants and toddlers. The apparatus includes a tube, which may be part of a syringe, including a fluid reservoir and a downstream opening, and a hollow elastomeric nipple which extends over a part of the tube and over the downstream opening in the tube so that the opening in the tube is generally aligned with the opening in the nipple. Preferably, the tube is frictionally held in place within the nipple with an interference fit. Numerous other features of the invention enhance the safety and effectiveness of the apparatus.
Various aspects of this invention will become apparent to those skilled in the art from the following detailed description of the preferred embodiment, when read in light of the accompanying drawings.
The tube 21 extends along a longitudinal directional flow axis A from a first upstream end 18 to a second downstream end 16. The upstream end 18 includes an upstream opening 19 and an optional annular flange 22 provided to facilitate the handling of the pediatric medicine delivery device 10. The downstream end 16 includes stepped frusto-conical outer surface portions 14 and 15 and has a downstream opening or delivery orifice 23. The tapered shape of the downstream end 16 is significant as it relates to the shape of the hollow nipple 30, but other shapes may be used as will be apparent. A plurality of indicia 26 is provided on the outer surface of the tube 21. The indicia 26 provide a visual indication of the amount of fluid that is disposed within the syringe tube 21.
The nipple 30 of the pediatric medicine delivery device 10 includes a mounting flange 31 and an annular groove 32. An integrally molded rib or nib 33 is provided in the groove 32. As will be described in detail below, the mounting flange 31, the groove 32, and the nib 33 are provided to facilitate the connection to and orientation of a faceplate 50. The nipple 30 is preferably formed from a conventional flexible elastomeric material, such as silicone or rubber, although any desired material can be used. The nipple 30 may be provided with one or more differently scented flavors (such as bubble gum, strawberry, and cherry, for example) to mask the taste of some medications and to make it more appealing for infants and toddlers. The scented nipples will help reduce the anxiety of taking medication.
The nipple 30 has an upstream end 34 that includes an upstream opening 35 and a downstream end or tip 36 having a downstream opening or spout 37. Downstream opening 37 is adapted to allow a fluid to flow therethrough when sucked upon by an infant or a toddler or when injected using a syringe. The nipple downstream opening 37 may be a traditional opening such as a pair of slits that are oriented in the shape of an X or any other desired shape to allow for the different types of viscosities found in different medications allowing the infant and toddlers to suck down the medicine. However, a preferred opening configuration will be explained in detail below.
Referring to
The nipple 30 is generally hollow, with frusto-conical steps 38 and 39 near the downstream end 36 and generally corresponding frusto-conical steps 14 and 15 of the tube 21. The tube steps 14 and 15 are slightly larger than the steps 38 and 39 to provide a frictional interference fit of the tube 21 within the nipple 30. The elastomeric nature of the nipple 30 allows for a secure but easily removable fit of the tube 21. When so secured, the delivery orifice 23 is disposed within the nipple 32 such that when the nipple 32 is sucked upon by an infant or a toddler, or when injected using a syringe, fluid medicine (not shown) disposed within the tube 21 with be ingested by the infant or toddler. The precise amount of such fluid medicine that is ingested by the infant or toddler can be quickly and easily determined by with reference to the indicia 26 provided on the syringe tube 21.
Referring to
Referring in addition to
The faceplate includes a design 60, which assists in proper orientation of the device 10. The design 60 may include animal or toy shapes, etc. to create a more interactive and fun experience for the infant or toddler. The orientation marking of
Referring to
The nipple interior is hollow, with a syringe tube pocket 43 including the frusto-conical surfaces 38 and 39 corresponding to the tube surfaces 14 and 15, and a cylindrical surface 41 corresponding to the outer surface diameter of the tube 21. The syringe pocket 43 is designed to correspond to the interior shape of the nipple 30 to secure the nipple to the syringe tube 21, but an additional benefit is that an infant or toddler can bite down on the nipple without closing the fluid delivery passageway through the tube and impeding fluid flow from the tube 21.
The purpose of the design of the spout or opening 37 is to prevent fluid form being forced directly down the throat of a user, which may otherwise occur if the syringe plunger is moved to quickly. The design of opening 37 allows fluid to be directed toward the cheeks of the user rather than directly at the throat. The orientation of the opening 37 is significant for this feature. To this end, the nib 33 is positioned in the groove 32 in alignment with the wall 70. Therefore, if the nib is positioned at the top or bottom of the device as it is inserted into the mouth of the user, the fluid will be deflected toward the cheeks of the user. In any event, in any orientation, the fluid will be deflected away from a path directly into the throat of the user.
The pacifier 130 includes a flange 131 and a nipple 132. The flange 131 and nipple 132 are integrally formed by molding. The nipple 132 has an upstream opening 135 and a downstream opening 137. The nipple 130 is generally hollow and has frusto-conical steps 138 and 139 adjacent the downstream end 136 generally corresponding to the frusto-conical steps 114 and 115 of the tube 121. The tube steps 114 and 115 are slightly larger than the steps 138 and 139 to provide a frictional interference fit of the tube 121 within the nipple 130.
The pediatric medicine delivery device 10 can be used to allow an infant or toddler to suck out the fluid contents, thereby controlling the fluid flow. Alternatively, the device 10 may be used by a caregiver to control the flow of fluid.
The principle and mode of operation of this invention have been explained and illustrated in its preferred embodiment. However, it must be understood that this invention may be practiced otherwise than as specifically explained and illustrated without departing from its spirit or scope.
This application claims the benefit of U.S. Provisional Application No. 61/661,647 filed Jun. 19, 2012, the disclosure of which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
1545436 | McGeary | Jul 1925 | A |
4184367 | Jenney et al. | Jan 1980 | A |
4821895 | Roskilly | Apr 1989 | A |
4923096 | Ennis, III | May 1990 | A |
5029701 | Roth et al. | Jul 1991 | A |
5114374 | Estiva | May 1992 | A |
5244122 | Botts | Sep 1993 | A |
5300024 | Yang | Apr 1994 | A |
5354274 | Demeter et al. | Oct 1994 | A |
5383906 | Burchett et al. | Jan 1995 | A |
5431680 | Jones | Jul 1995 | A |
5512047 | Dvorak | Apr 1996 | A |
5620462 | Valenti | Apr 1997 | A |
5662684 | Caso | Sep 1997 | A |
5728137 | Anderson-Fignon | Mar 1998 | A |
5772685 | Crowe et al. | Jun 1998 | A |
5810886 | Hassan | Sep 1998 | A |
5843030 | Van Der Merwe | Dec 1998 | A |
5891165 | Buckner | Apr 1999 | A |
5932262 | Little | Aug 1999 | A |
6110193 | Chen | Aug 2000 | A |
6139566 | Bennett | Oct 2000 | A |
6270519 | Botts | Aug 2001 | B1 |
6454788 | Ashton | Sep 2002 | B1 |
6547808 | Tuckey et al. | Apr 2003 | B2 |
7320678 | Ruth et al. | Jan 2008 | B2 |
7753886 | Vath et al. | Jul 2010 | B2 |
8141551 | Wachter | Mar 2012 | B2 |
20060079814 | Barlow et al. | Apr 2006 | A1 |
20080196716 | Wachter | Aug 2008 | A1 |
20080223807 | Botts | Sep 2008 | A1 |
20110295197 | Hazan | Dec 2011 | A1 |
20130030379 | Ingram et al. | Jan 2013 | A1 |
20140051926 | Oates et al. | Feb 2014 | A1 |
Number | Date | Country | |
---|---|---|---|
61661647 | Jun 2012 | US |